Nuveen’s TuHURA Biosciences HURA Stock Holding History

Nuveen’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33,575	Closed	-$60.1K	–	3862
2026 Q1	$60.1K	Hold	33,575	–	–	﹤0.01%	3199
2025 Q4	$25.4K	Hold	33,575	–	–	﹤0.01%	3245
2025 Q3	$83.3K	Hold	33,575	–	–	﹤0.01%	3236
2025 Q2	$74.9K	Buy	+33,575	New	+$113K	﹤0.01%	3260

Other funds holding HURA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Nuveen's HURA Position: Q2 2026 in Review

Nuveen sold out of TuHURA Biosciences (HURA) in Q2 2026, closing a stake of 33,575 shares — an estimated $60.1K sold.

Nuveen first reported a position in HURA in Q2 2025 and held it in 4 quarters. The position peaked at $83.3K in Q3 2025. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

Nuveen reported no remaining TuHURA Biosciences position as of Q2 2026 after selling out during the quarter.
Nuveen sold 33,575 TuHURA Biosciences shares in Q2 2026, an estimated $60.1K.
Nuveen first reported a position in TuHURA Biosciences in Q2 2025 and held it in 4 quarters.
Nuveen's TuHURA Biosciences position peaked at $83.3K in Q3 2025.
90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.